The nature of an in vivo anti-capsular polysaccharide response is markedly influenced by the composition and/or architecture of the bacterial subcapsular domain

Journal of Immunology

Volumn 188, Issue 2, 2012, Pages 569-577

  Arjunaraja, Swadhinya ^a,b   Massari, Paola ^c   Wetzler, Lee M ^c   Lees, Andrew ^d   Colino, Jesus ^a   Snapper, Clifford M ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b BIRLA INSTITUTE OF TECHNOLOGY AND SCIENCE   (India)

^c BOSTON UNIVERSITY   (United States)

^d Fina Biosolutions LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL POLYSACCHARIDE; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN M; PROTEIN A;

ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; BACTERIAL CELL; BACTERIUM IDENTIFICATION; CD4+ T LYMPHOCYTE; CELL ISOLATION; CONTROLLED STUDY; IMMUNE RESPONSE; IMMUNIZATION; IN VIVO STUDY; INTERMETHOD COMPARISON; MOLECULAR DYNAMICS; MOUSE; NEISSERIA MENINGITIDIS; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE;

ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL CAPSULES; CELLS, CULTURED; FEMALE; IMMUNIZATION, SECONDARY; IMMUNOGLOBULIN G; LIPOPOLYSACCHARIDES; MENINGOCOCCAL VACCINES; MICE; MICE, 129 STRAIN; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, NUDE; MICE, TRANSGENIC; NEISSERIA MENINGITIDIS, SEROGROUP C; POLYSACCHARIDES, BACTERIAL; PROTEIN STRUCTURE, TERTIARY; VACCINES, CONJUGATE;

EID: 84856011669     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1101446     Document Type: Article

References (60)

1. Klein Klouwenberg, P., and L. Bont. 2008. Neonatal and infantile immune responses to encapsulated bacteria and conjugate vaccines. Clin. Dev. Immunol. 2008: 628963.
2. AlonsoDeVelasco, E., A. F. Verheul, J. Verhoef, and H. Snippe. 1995. Streptococcus pneumoniae: virulence factors, pathogenesis, and vaccines. Microbiol. Rev. 59: 591-603.
3. Harding, C. V., R. W. Roof, P. M. Allen, and E. R. Unanue. 1991. Effects of pH and polysaccharides on peptide binding to class II major histocompatibility complex molecules. Proc. Natl. Acad. Sci. USA 88: 2740-2744. (Pubitemid 21916494)
4. Ishioka, G. Y., A. G. Lamont, D. Thomson, N. Bulbow, F. C. Gaeta, A. Sette, and H. M. Grey. 1992. MHC interaction and T cell recognition of carbohydrates and glycopeptides. J. Immunol. 148: 2446-2451.
5. Mond, J. J., A. Lees, and C. M. Snapper. 1995. T cell-independent antigens type 2. Annu. Rev. Immunol. 13: 655-692.
6. Brunswick, M., F. D. Finkelman, P. F. Highet, J. K. Inman, H. M. Dintzis, and J. J. Mond. 1988. Picogram quantities of anti-Ig antibodies coupled to dextran induce B cell proliferation. J. Immunol. 140: 3364-3372.
7. Snapper, C. M., and J. J. Mond. 1996. A model for induction of T cell-independent humoral immunity in response to polysaccharide antigens. J. Immunol. 157: 2229-2233. (Pubitemid 126450429)
8. Guttormsen, H. K., L. M. Wetzler, R. W. Finberg, and D. L. Kasper. 1998. Immunologic memory induced by a glycoconjugate vaccine in a murine adoptive lymphocyte transfer model. Infect. Immun. 66: 2026-2032.
9. Khan, A. Q., A. Lees, and C. M. Snapper. 2004. Differential regulation of IgG anti-capsular polysaccharide and antiprotein responses to intact Streptococcus pneumoniae in the presence of cognate CD4+ T cell help. J. Immunol. 172: 532-539. (Pubitemid 38020510)
10. Chen, Q., J. L. Cannons, J. C. Paton, H. Akiba, P. L. Schwartzberg, and C. M. Snapper. 2008. A novel ICOS-independent, but CD28- and SAP-dependent, pathway of T cell-dependent, polysaccharide-specific humoral immunity in response to intact Streptococcus pneumoniae versus pneumococcal conjugate vaccine. J. Immunol. 181: 8258-8266.
11. Snapper, C. M. 2006. Differential regulation of protein- and polysaccharide-specific Ig isotype production in vivo in response to intact Streptococcus pneumoniae. Curr. Protein Pept. Sci. 7: 295-305.
12. Chattopadhyay, G., A. Q. Khan, G. Sen, J. Colino, W. DuBois, A. Rubtsov, R. M. Torres, M. Potter, and C. M. Snapper. 2007. Transgenic expression of BclxL or Bcl-2 by murine B cells enhances the in vivo antipolysaccharide, but not antiprotein, response to intact Streptococcus pneumoniae. J. Immunol. 179: 7523-7534.
13. Lanoue, A., M. R. Clatworthy, P. Smith, S. Green, M. J. Townsend, H. E. Jolin, K. G. Smith, P. G. Fallon, and A. N. McKenzie. 2004. SIGN-R1 contributes to protection against lethal pneumococcal infection in mice. J. Exp. Med. 200: 1383-1393. (Pubitemid 39657286)
14. Dintzis, H. M., R. Z. Dintzis, and B. Vogelstein. 1976. Molecular determinants of immunogenicity: the immunon model of immune response. Proc. Natl. Acad. Sci. USA 73: 3671-3675.
15. Kalka-Moll, W. M., A. O. Tzianabos, P. W. Bryant, M. Niemeyer, H. L. Ploegh, and D. L. Kasper. 2002. Zwitterionic polysaccharides stimulate T cells by MHC class II-dependent interactions. J. Immunol. 169: 6149-6153. (Pubitemid 36903459)
16. Courtney, A. H., E. B. Puffer, J. K. Pontrello, Z. Q. Yang, and L. L. Kiessling. 2009. Sialylated multivalent antigens engage CD22 in trans and inhibit B cell activation. Proc. Natl. Acad. Sci. USA 106: 2500-2505.
17. Kanswal, S., N. Katsenelson, W. Allman, K. Uslu, M. S. Blake, and M. Akkoyunlu. 2011. Suppressive effect of bacterial polysaccharides on BAFF system is responsible for their poor immunogenicity. J. Immunol. 186: 2430-2443.
18. Grabitzki, J., and G. Lochnit. 2009. Immunomodulation by phosphocholine - biosynthesis, structures and immunological implications of parasitic PC-epitopes. Mol. Immunol. 47: 149-163.
19. Sørensen, U. B., J. Henrichsen, H. C. Chen, and S. C. Szu. 1990. Covalent linkage between the capsular polysaccharide and the cell wall peptidoglycan of Streptococcus pneumoniae revealed by immunochemical methods. Microb. Pathog. 8: 325-334. (Pubitemid 20303859)
20. Jedrzejas, M. J. 2004. Extracellular virulence factors of Streptococcus pneumoniae. Front. Biosci. 9: 891-914. (Pubitemid 39043760)
21. Ellis, T. N., and M. J. Kuehn. 2010. Virulence and immunomodulatory roles of bacterial outer membrane vesicles. Microbiol. Mol. Biol. Rev. 74: 81-94.
22. Massari, P., P. Henneke, Y. Ho, E. Latz, D. T. Golenbock, and L. M. Wetzler. 2002. Cutting edge: Immune stimulation by neisserial porins is toll-like receptor 2 and MyD88 dependent. J. Immunol. 168: 1533-1537. (Pubitemid 34135744)
23. Beuvery, E. C., F. Miedema, R. W. van Delft, J. Haverkamp, A. B. Leussink, B. J. te Pas, K. S. Teppema, and R. H. Tiesjema. 1983. Preparation and physicochemical and immunological characterization of polysaccharide-outer membrane protein complexes of Neisseria meningitidis. Infect. Immun. 40: 369-380. (Pubitemid 13163078)
24. Colino, J., and I. Outschoorn. 1998. Dynamics of the murine humoral immune response to Neisseria meningitis group B capsular polysaccharide. Infect. Immun. 66: 505-513. (Pubitemid 28074189)
25. Kocabas, C., N. Katsenelson, S. Kanswal, M. N. Kennedy, X. Cui, M. S. Blake, D. M. Segal, and M. Akkoyunlu. 2007. Neisseria meningitidis type C capsular polysaccharide inhibits lipooligosaccharide-induced cell activation by binding to CD14. Cell. Microbiol. 9: 1297-1310. (Pubitemid 46547145)
26. Colino, J., G. Chattopadhyay, G. Sen, Q. Chen, A. Lees, D. H. Canaday, A. Rubtsov, R. Torres, and C. M. Snapper. 2009. Parameters underlying distinct T cell-dependent polysaccharide-specific IgG responses to an intact gram-positive bacterium versus a soluble conjugate vaccine. J. Immunol. 183: 1551-1559.
27. Sen, G., M. Flora, G. Chattopadhyay, D. M. Klinman, A. Lees, J. J. Mond, and C. M. Snapper. 2004. The critical DNA flanking sequences of a CpG oligodeoxynucleotide, but not the 6 base CpG motif, can be replaced with RNA without quantitative or qualitative changes in Toll-like receptor 9-mediated activity. Cell. Immunol. 232: 64-74. (Pubitemid 40732721)
28. Tommassen, J., P. Vermeij, M. Struyvé, R. Benz, and J. T. Poolman. 1990. Isolation of Neisseria meningitidis mutants deficient in class 1 (porA) and class 3 (porB) outer membrane proteins. Infect. Immun. 58: 1355-1359. (Pubitemid 20151800)
29. Massari, P., C. A. King, H. MacLeod, and L. M. Wetzler. 2005. Improved purification of native meningococcal porin PorB and studies on its structure/function. Protein Expr. Purif. 44: 136-146. (Pubitemid 41565562)
30. Greenwald, R. J., G. J. Freeman, and A. H. Sharpe. 2005. The B7 family revisited. Annu. Rev. Immunol. 23: 515-548. (Pubitemid 40563179)
31. Liang, L., andW. C. Sha. 2002. The right place at the right time: novel B7 family members regulate effector T cell responses. Curr. Opin. Immunol. 14: 384-390. (Pubitemid 34327983)
32. Dong, C., A. E. Juedes, U. A. Temann, S. Shresta, J. P. Allison, N. H. Ruddle, and R. A. Flavell. 2001. ICOS co-stimulatory receptor is essential for T-cell activation and function. Nature 409: 97-101. (Pubitemid 32098632)
33. Hutloff, A., A. M. Dittrich, K. C. Beier, B. Eljaschewitsch, R. Kraft, I. Anagnostopoulos, and R. A. Kroczek. 1999. ICOS is an inducible T-cell costimulator structurally and functionally related to CD28. Nature 397: 263-266.
34. Elgueta, R., M. J. Benson, V. C. de Vries, A. Wasiuk, Y. Guo, and R. J. Noelle. 2009. Molecular mechanism and function of CD40/CD40L engagement in the immune system. Immunol. Rev. 229: 152-172.
35. Guttormsen, H. K., A. H. Sharpe, A. K. Chandraker, A. K. Brigtsen, M. H. Sayegh, and D. L. Kasper. 1999. Cognate stimulatory B-cell-T-cell interactions are critical for T-cell help recruited by glycoconjugate vaccines. Infect. Immun. 67: 6375-6384.
36. Jeurissen, A., M. Wuyts, A. Kasran, S. Ramdien-Murli, L. Boon, J. L. Ceuppens, and X. Bossuyt. 2002. Essential role for CD40 ligand interactions in T lymphocyte-mediated modulation of the murine immune response to pneumococcal capsular polysaccharides. J. Immunol. 168: 2773-2781. (Pubitemid 34211656)
37. Kawabe, T., T. Naka, K. Yoshida, T. Tanaka, H. Fujiwara, S. Suematsu, N. Yoshida, T. Kishimoto, and H. Kikutani. 1994. The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation. Immunity 1: 167-178.
38. Renshaw, B. R., W. C. Fanslow, III, R. J. Armitage, K. A. Campbell, D. Liggitt, B. Wright, B. L. Davison, and C. R. Maliszewski. 1994. Humoral immune responses in CD40 ligand-deficient mice. J. Exp. Med. 180: 1889-1900. (Pubitemid 24328578)
39. Foy, T. M., J. D. Laman, J. A. Ledbetter, A. Aruffo, E. Claassen, and R. J. Noelle. 1994. gp39-CD40 interactions are essential for germinal center formation and the development of B cell memory. J. Exp. Med. 180: 157-163. (Pubitemid 24181064)
40. Akira, S., and K. Takeda. 2004. Toll-like receptor signalling. Nat. Rev. Immunol. 4: 499-511. (Pubitemid 38931765)
41. Khan, A. Q., Q. Chen, Z. Q. Wu, J. C. Paton, and C. M. Snapper. 2005. Both innate immunity and type 1 humoral immunity to Streptococcus pneumoniae are mediated by MyD88 but differ in their relative levels of dependence on toll-like receptor 2. Infect. Immun. 73: 298-307. (Pubitemid 40041121)
42. Obukhanych, T. V., and M. C. Nussenzweig. 2006. T-independent type II immune responses generate memory B cells. J. Exp. Med. 203: 305-310. (Pubitemid 43290839)
43. Avery, O. T., and W. F. Goebel. 1931. Chemo-immunological studies on conjugated carbohydrate-proteins. V. The immunological specificity of an antigen prepared by combining the capsular polysaccharide of type III pneumococcus with foreign protein. J. Exp. Med. 54: 437-447.
44. Muthukkumar, S., and K. E. Stein. 2004. Immunization with meningococcal polysaccharide-tetanus toxoid conjugate induces polysaccharide-reactive T cells in mice. Vaccine 22: 1290-1299. (Pubitemid 38296674)
45. Whitfield, C. 2006. Biosynthesis and assembly of capsular polysaccharides in Escherichia coli. Annu. Rev. Biochem. 75: 39-68. (Pubitemid 44118025)
46. Lucas, A. H., and D. C. Reason. 1999. Polysaccharide vaccines as probes of antibody repertoires in man. Immunol. Rev. 171: 89-104. (Pubitemid 29504712)
47. Zhou, J., K. R. Lottenbach, S. J. Barenkamp, and D. C. Reason. 2004. Somatic hypermutation and diverse immunoglobulin gene usage in the human antibody response to the capsular polysaccharide of Streptococcus pneumoniae Type 6B. Infect. Immun. 72: 3505-3514. (Pubitemid 38697777)
48. Sette, A., M. Moutaftsi, J. Moyron-Quiroz, M. M. McCausland, D. H. Davies, R. J. Johnston, B. Peters, M. Rafii-El-Idrissi Benhnia, J. Hoffmann, H. P. Su, et al. 2008. Selective CD4+ T cell help for antibody responses to a large viral pathogen: deterministic linkage of specificities. Immunity 28: 847-858. (Pubitemid 351778408)
49. Souwer, Y., A. Griekspoor, T. Jorritsma, J. de Wit, H. Janssen, J. Neefjes, and S. M. van Ham. 2009. B cell receptor-mediated internalization of salmonella: a novel pathway for autonomous B cell activation and antibody production. J. Immunol. 182: 7473-7481.
50. Klaus, G. G., and J. H. Humphrey. 1974. The immunological properties of haptens coupled to thymus-independent carrier molecules. I. The characteristics of the immune response to dinitrophenyl-lysine-substituted pneumococcal polysaccharide (SIII) and levan. Eur. J. Immunol. 4: 370-377.
51. Baker, P. J., P. W. Stashak, D. F. Amsbaugh, and B. Prescott. 1971. Characterization of the antibody response to type 3 pneumococcal polysaccharide at the cellular level. I. Dose-response studies and the effect of prior immunization on the magnitude of the antibody response. Immunology 20: 469-480.
52. Koppel, E. A., C. W.Wieland, V. C. van den Berg, M. Litjens, S. Florquin, Y. van Kooyk, T. van der Poll, and T. B. Geijtenbeek. 2005. Specific ICAM-3 grabbing nonintegrin-related 1 (SIGNR1) expressed by marginal zone macrophages is essential for defense against pulmonary Streptococcus pneumoniae infection. Eur. J. Immunol. 35: 2962-2969. (Pubitemid 41555092)
53. Chen, Z., S. B. Koralov, and G. Kelsoe. 2000. Regulation of humoral immune responses by CD21/CD35. Immunol. Rev. 176: 194-204.
54. Harwood, N. E., and F. D. Batista. 2008. New insights into the early molecular events underlying B cell activation. Immunity 28: 609-619. (Pubitemid 351636250)
55. Pridmore, A. C., D. H. Wyllie, F. Abdillahi, L. Steeghs, P. van der Ley, S. K. Dower, and R. C. Read. 2001. A lipopolysaccharide-deficient mutant of Neisseria meningitidis elicits attenuated cytokine release by human macrophages and signals via toll-like receptor (TLR) 2 but not via TLR4/MD2. J. Infect. Dis. 183: 89-96. (Pubitemid 32043045)
56. Sen, G., A. Q. Khan, Q. Chen, and C. M. Snapper. 2005. In vivo humoral immune responses to isolated pneumococcal polysaccharides are dependent on the presence of associated TLR ligands. J. Immunol. 175: 3084-3091. (Pubitemid 41170528)
57. Trinchieri, G. 2003. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 3: 133-146. (Pubitemid 37328691)
58. Snapper, C. M., and W. E. Paul. 1987. Interferon-γ and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science 236: 944-947. (Pubitemid 17107942)
59. Snapper, C. M., F. Rosas, M. A. Moorman, L. Jin, K. Shanebeck, D. M. Klinman, M. R. Kehry, J. J. Mond, and C. R. Maliszewski. 1996. IFN-γ is a potent inducer of Ig secretion by sort-purified murine B cells activated through the mIg, but not the CD40, signaling pathway. Int. Immunol. 8: 877-885.
60. Yamamoto, M., S. Sato, K. Mori, K. Hoshino, O. Takeuchi, K. Takeda, and S. Akira. 2002. Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-β promoter in the Toll-like receptor signaling. J. Immunol. 169: 6668-6672. (Pubitemid 36899248)